Are hospitalization costs for acute ischemic stroke patients treated with intravenous thrombolysis in the United States substantially higher than medicare payments?
Hospitalization costs for patients treated with intravenous thrombolysis are substantially higher than Medicare payments.
These findings strongly indicate that SAL-2 stabilizes age-related redox imbalance and modulates the signal transduction pathway involved in the age-associated molecular inflammatory process.